Anebulo Pharmaceuticals, Inc. (ANEB) stock
Close on Oct 19, 2026Market cap $28.76KP/E –Yield –
Earnings
Anebulo Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Anebulo Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2026ended Dec 31, 2025 | Feb 12, 2026during market hours | – | – | -$0.05 | Release |
| Q1 FY2026ended Sep 30, 2025 | Nov 13, 2025during market hours | – | – | -$0.05 | Release |
| Q4 FY2025ended Jun 30, 2025 | Sep 29, 2025during market hours | – | – | -$0.05 | Release |
| Q3 FY2025ended Mar 31, 2025 | May 13, 2025during market hours | – | – | – | Release |
| Q2 FY2025ended Dec 31, 2024 | Feb 14, 2025during market hours | – | – | -$0.09 | Release |
| Q1 FY2025ended Sep 30, 2024 | Nov 13, 2024during market hours | – | – | -$0.08 | Release |
| Q4 FY2024ended Jun 30, 2024 | Sep 25, 2024during market hours | – | – | -$0.05 | Release |
| Q3 FY2024ended Mar 31, 2024 | May 15, 2024during market hours | – | – | -$0.06 | Release |
| Q2 FY2024ended Dec 31, 2023 | Feb 13, 2024during market hours | – | – | – | Release |
| Q1 FY2024ended Sep 30, 2023 | Nov 14, 2023during market hours | – | – | – | Release |
| Q4 FY2023ended Jun 30, 2023 | Sep 20, 2023during market hours | – | – | – | Release |
| Q3 FY2023ended Mar 31, 2023 | May 11, 2023before the open | – | – | – | Release |
| Q2 FY2023ended Dec 31, 2022 | Feb 10, 2023before the open | – | – | – | Release |
| Q1 FY2023ended Sep 30, 2022 | Nov 10, 2022before the open | – | – | – | Release |
| Q4 FY2022ended Jun 30, 2022 | Sep 9, 2022before the open | – | – | – | Release |
| Q3 FY2022ended Mar 31, 2022 | May 11, 2022before the open | – | – | – | Release |
| Q2 FY2022ended Dec 31, 2021 | Feb 11, 2022before the open | – | – | – | Release |
| Q1 FY2022ended Sep 30, 2021 | Nov 12, 2021before the open | – | – | – | Release |
| Q4 FY2021ended Jun 30, 2021 | Sep 22, 2021during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Anebulo Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Anebulo Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Anebulo Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- News
- News
- News
- Results
- Results
- News
- News
- Results
- Results
- News
- Results
- Update
- Results
See a number that looks wrong?